These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37900415)

  • 1. Antibiotic Resistance: Challenges and Strategies in Combating Infections.
    Chavada J; Muneshwar KN; Ghulaxe Y; Wani M; Sarda PP; Huse S
    Cureus; 2023 Sep; 15(9):e46013. PubMed ID: 37900415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics.
    Murugaiyan J; Kumar PA; Rao GS; Iskandar K; Hawser S; Hays JP; Mohsen Y; Adukkadukkam S; Awuah WA; Jose RAM; Sylvia N; Nansubuga EP; Tilocca B; Roncada P; Roson-Calero N; Moreno-Morales J; Amin R; Kumar BK; Kumar A; Toufik AR; Zaw TN; Akinwotu OO; Satyaseela MP; van Dongen MBM
    Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage-delivered sensitisation with subsequent antibiotic treatment reveals sustained effect against antimicrobial resistant bacteria.
    Liu H; Li H; Liang Y; Du X; Yang C; Yang L; Xie J; Zhao R; Tong Y; Qiu S; Song H
    Theranostics; 2020; 10(14):6310-6321. PubMed ID: 32483454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
    Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
    Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans".
    Baptista PV; McCusker MP; Carvalho A; Ferreira DA; Mohan NM; Martins M; Fernandes AR
    Front Microbiol; 2018; 9():1441. PubMed ID: 30013539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics for ventilator-associated pneumonia.
    Arthur LE; Kizor RS; Selim AG; van Driel ML; Seoane L
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004267. PubMed ID: 27763732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
    Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
    Elife; 2022 Jan; 11():. PubMed ID: 35025730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoantibiotics: A Novel Rational Approach to Antibiotic Resistant Infections.
    Engin AB; Engin A
    Curr Drug Metab; 2019; 20(9):720-741. PubMed ID: 31385767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The food safety perspective of antibiotic resistance.
    McDermott PF; Zhao S; Wagner DD; Simjee S; Walker RD; White DG
    Anim Biotechnol; 2002 May; 13(1):71-84. PubMed ID: 12212946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems.
    Imran M; Jha SK; Hasan N; Insaf A; Shrestha J; Shrestha J; Devkota HP; Khan S; Panth N; Warkiani ME; Dua K; Hansbro PM; Paudel KR; Mohammed Y
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly parallelized droplet cultivation and prioritization of antibiotic producers from natural microbial communities.
    Mahler L; Niehs SP; Martin K; Weber T; Scherlach K; Hertweck C; Roth M; Rosenbaum MA
    Elife; 2021 Mar; 10():. PubMed ID: 33764297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Strategies to Combat Bacterial Drug Resistance: Antimicrobial Materials and Drug Delivery Systems.
    Yao J; Zou P; Cui Y; Quan L; Gao C; Li Z; Gong W; Yang M
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance.
    Abavisani M; Khayami R; Hoseinzadeh M; Kodori M; Kesharwani P; Sahebkar A
    Drug Resist Updat; 2023 May; 68():100948. PubMed ID: 36780840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on Usage of Functional Nanomaterials in Antimicrobial Therapy for Antibiotic-Resistant Bacterial Infections.
    Karnwal A; Kumar G; Pant G; Hossain K; Ahmad A; Alshammari MB
    ACS Omega; 2023 Apr; 8(15):13492-13508. PubMed ID: 37091369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging antibiotic resistance: carbapenemase-producing enterobacteria. Bad new bugs, still no new drugs.
    Spera AM; Esposito S; Pagliano P
    Infez Med; 2019 Dec; 27(4):357-364. PubMed ID: 31846984
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.